Aberer Elisabeth, Bergmann Andreas R, Derler Anna-Maria, Schmidt Bruno
Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, Austria.
Acta Derm Venereol. 2007;87(1):39-42. doi: 10.2340/00015555-0172.
Diagnosis of Lyme borreliosis by urine polymerase chain reaction (PCR) has been recognized as having better diagnostic sensitivity in patients with erythema migrans than serological methods. We made serial tests with 192 urine specimens from 70 patients with erythema migrans and 60 urine specimens from 21 patients with acrodermatitis chronica atrophicans to evaluate the course of positive urine PCR after antibiotic treatment. Before treatment, urine samples from patients with erythema migrans showed a positive PCR in 27/34 samples (79%), and those from patients with acrodermatitis chronica atrophicans in 7/11 (63%). The specificity of bands was proven by hybridization with GEN-ETI-KTM-DEIA kit in 40/41 samples. Borrelia DNA in urine decreased gradually within the observation period of one year in both patients with erythema migrans and acrodermatitis chronica atrophicans, and persisted without clinical symptoms in 4/45 patients with erythema migrans (8%) after 12 months. Urine PCR can serve as a diagnostic method in early Lyme borreliosis and also in seropositive patients with unclear clinical symptoms.
通过尿液聚合酶链反应(PCR)诊断莱姆病螺旋体病,已被认为在游走性红斑患者中比血清学方法具有更高的诊断敏感性。我们对70例游走性红斑患者的192份尿液标本以及21例慢性萎缩性肢端皮炎患者的60份尿液标本进行了系列检测,以评估抗生素治疗后尿液PCR阳性的病程。治疗前,游走性红斑患者的尿液样本中27/34份(79%)PCR呈阳性,慢性萎缩性肢端皮炎患者的尿液样本中7/11份(63%)PCR呈阳性。40/41份样本通过与GEN-ETI-KTM-DEIA试剂盒杂交证实了条带的特异性。在游走性红斑患者和慢性萎缩性肢端皮炎患者中,尿液中的伯氏疏螺旋体DNA在一年的观察期内逐渐减少,12个月后,4/45例游走性红斑患者(8%)的尿液中仍持续存在伯氏疏螺旋体DNA但无临床症状。尿液PCR可作为早期莱姆病螺旋体病以及血清学阳性但临床症状不明确患者的诊断方法。